Investing.com - Fresenius Medical Care ADR reported third quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.
The firm reported earnings per share of $0.41 on revenue of $5.3B. Analysts polled by Investing.com anticipated EPS of $0.39 on revenue of $5.01B. .
Fresenius Medical Care ADR follows other major Healthcare sector earnings this month
On Tuesday, November 1, 2022, Eli Lilly reported third quarter EPS of $1.98 on revenue of $6.94B, compared to forecasts of EPS of $1.91 on revenue of $6.91B.
Pfizer earnings beat analyst's expectations on Tuesday, November 1, 2022, with third quarter EPS of $1.78 on revenue of $22.6B. Investing.com analysts expected EPS of $1.44 on revenue of $21.33B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar